About Regeners
Regeners is a company based in Yuseong (South Korea) founded in 2021 by Ha-gang Kim. Regeners offers products and services including Stem Cell Therapeutics and Direct Reprogramming Technology. Regeners operates in a competitive market with competitors including UCB, Cellino, NuVasive, Ensoma and Aspen Neuroscience, among others.
- Headquarter Yuseong, South Korea
- Founders Ha-gang Kim
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name ㈜리제너스
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Regeners
Regeners offers a comprehensive portfolio of products and services, including Stem Cell Therapeutics and Direct Reprogramming Technology.
Develops treatments for Parkinson's using direct reprogramming technology.
Enables efficient cell conversion for disease therapies.
Funding Insights of Regeners
Detailed funding history for Regeners
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Regeners
Investment portfolio details for Regeners
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Regeners
Detailed financials for Regeners
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Regeners Comparisons
Peer comparison for Regeners
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Regeners
Regeners operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as UCB, Cellino, NuVasive, Ensoma and Aspen Neuroscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for immunological and neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Developer of autologous cell therapies
|
|
| Locked | Locked | Locked |
Smart surgical devices for spinal surgery are developed.
|
|
| Locked | Locked | Locked |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| Locked | Locked | Locked |
Provider of genomic-based personalised pluripotent stem cell therapy
|
|
| Locked | Locked | Locked |
Products for regenerative and respiratory medicine are developed and distributed.
|
Detailed competitors of Regeners
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Regeners
Complete news archive for Regeners
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Regeners
Regeners was founded in 2021.
Regeners is headquartered in Yuseong, South Korea. It is registered at Yuseong, Daejeon, South Korea.
Ha-gang Kim is the current CEO of Regeners. They have also founded this company.
Regeners was founded in 2021 and is based in Yuseong, South Korea. Operations focus on the biotechnology sector, where stem cell therapeutics are advanced through a direct cross-differentiation platform. Regenerative therapies offered include RG101, an autologous cell therapy for Parkinsons disease that involves creating and transplanting patient-specific dopaminergic neurons, and RG201 for macular degeneration. Development emphasizes patient-specific treatments in neurology and ophthalmology.
Regeners offers Stem Cell Therapeutics and Direct Reprogramming Technology.